Cleary Gottlieb Steen & Hamilton is representing GSK plc in the transaction. SK plc (GSK) entered into an agreement on January 8, 2024 to acquire Aiolos Bio,...
GSK’s Acquisition of Aiolos
GSK’s Licensing Agreement with Hansoh Pharma for HS-20093
Davis Polk & Wardwell advised GSK on the transaction. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
GSK’s Licensing Agreement with Hansoh Pharma
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
23andMe’s New Data Licensing Agreement with GSK
Davis Polk & Wardwell advised GSK on the deal. 23andMe Holding Co. (Nasdaq: ME) (“23andMe”) announced a new non-exclusive data license with GSK plc (LSE/NYSE: GSK) which...
GSK and Pfizer’s Demerger of Haleon
Wachtell, Lipton, Rosen & Katz and Clifford Chance served as Pfizer’s legal advisors, and Skadden, Arps, Slate, Meagher & Flom served as its tax advisor for...